Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population - Wikidata - awgldk - TriplyDB

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

http://www.wikidata.org/entity/Q27473164

about

Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity program Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base Health status of prisoners in Canada: Narrative review Treatment outcomes with pegylated interferon and ribavirin for male prisoners with chronic hepatitis C Hepatitis C in European prisons: a call for an evidence-informed response HCV infected prisoners: should they be still considered a difficult to treat population?Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting.A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.Clinical outcomes of hepatitis C treatment in a prison setting: feasibility and effectiveness for challenging treatment populations Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.Prisons and HCV: a review and a report on an experience in New South Wales Australia.High prevalence of late relapse and reinfection in prisoners treated for chronic hepatitis C.Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.Hepatitis C in Australian prisons: a national needs assessment.Efficacy of chronic hepatitis C therapy with pegylated interferon and ribavirin in patients on methadone maintenance treatment.Genotype distribution and treatment response among incarcerated drug-dependent patients with chronic hepatitis C infection.Survey of US Correctional Institutions for Routine HCV Testing.Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015

P2860

Q24676385-B244C9BA-3E50-4BEF-A034-93638904CD14 Q26785981-ABB2F3A9-1307-4781-8E9B-54A75B73B170 Q26853671-167840CC-338E-4505-8BB7-0924B47252A4 Q27010015-5FC9B473-F2B9-4F27-A9E2-91B4B31FE3D8 Q28067044-E1775F06-CCF6-4976-BD86-5D259821BE03 Q34113801-C369A39F-183A-4355-8333-74C1EA84EB1A Q34260664-AA51BE64-F07C-49EC-8D73-2B742A51FEAC Q34941459-4B134C35-2975-4586-91F5-6D3186C0CECF Q35020696-89CC69FB-F042-42A8-A37D-FF207E4D5360 Q36571408-904FD8C5-12EC-4BCC-A6F2-E3D7EA276D92 Q36843554-E8A5809B-4DD4-4D31-B382-DF0A2AB6B4B7 Q37216987-69A9D8FD-1765-4959-BB6A-7E457189DFA5 Q37242489-5971244A-6E25-4C2C-B889-377A8445B31D Q37769280-4AD05CCE-6E41-4128-A9C6-8AF3D9E4C034 Q38077758-E24539BB-A17B-449F-BBBA-BC389C1E5AF6 Q38382431-B6B97591-9FE4-4EB6-8F05-462D9D96C82E Q43041036-B982151A-A37D-4047-BC2F-9561ED61E42E Q47547173-84E7B00A-F7EE-41F5-A39B-9F35A827B569 Q55424407-6EBCCBDA-5733-4BDD-AD1F-461CC8ED6DEB Q56889456-ABE2295B-D42F-45ED-B520-1628CA518A3E

P2860

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

http://www.wikidata.org/entity/Q27473164

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@ast

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@en

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@nl

type

label

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@ast

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@en

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@nl

prefLabel

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@ast

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@en

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@nl

P1433

Q27473164-96A2A05E-1942-411B-BEAD-D109CC8D48CC

P1476

Q27473164-46DF1083-F905-4798-9253-33830C5F8573

P2093

Q27473164-0B96BD1E-2B43-42C3-B294-79CA751A999B

Q27473164-15F4565B-4E6A-44D3-B53F-8063EB88F6C1

Q27473164-51EB6787-7A02-423F-A2E6-61CDFEAA0687

Q27473164-C1948319-8EF8-4DF3-A0E8-DE14EFB405EE

Q27473164-FAE698FD-B0B8-4F38-9BE8-FDCC7DF276D9

P2860

Q27473164-3DC03B4B-D1C8-4387-B97C-5259E4A1CE81

Q27473164-3E18A248-3DDC-4C62-AF48-843EE74D61E1

Q27473164-44B7A204-7728-4CC3-B96B-BCDF59731F58

Q27473164-6A2680B2-CB04-480F-A09C-37E1B447F443

Q27473164-84ED2053-F9CB-4A09-9CA9-A9C6F8E4595D

Q27473164-85EC3115-1195-4BF5-AF1F-985C793E6F46

Q27473164-8F310044-8C2B-4785-849F-3895C9324C81

Q27473164-9B95E640-26FF-4A25-87B3-12181C3B9C69

Q27473164-D75E4537-A50C-4069-A00B-AD3CCDA779CE

Q27473164-DBD73CB6-8CCB-41DB-9AC6-C6CFA3C6498B

P304

Q27473164-BF5EEAA9-1710-4F32-9538-6DB362FD393C

P31

Q27473164-39EEA86C-955A-4CE4-A95F-38C26DF9CB0D

P356

Q27473164-110F6BFB-7B94-4ED3-9017-AB07A4A00464

P407

Q27473164-E010BF9D-5AD1-434A-803D-BC1428550583

P433

Q27473164-4C022974-DF50-4CB6-9B0D-CD506D1ED600

P478

Q27473164-375FF445-B279-4650-88BF-420A12DB046A

P50

Q27473164-6D796297-4776-4B3A-A50B-11B0F0FA16C7

P577

Q27473164-6C3A6B47-3780-447A-A2D0-E12775F6CFCC

P5875

Q27473164-221DAAE6-62B2-4FC3-B2E3-718584A2DB1E

P698

Q27473164-DBE5E1CB-7573-4C3D-9EE4-21E7E413F362

P932

Q27473164-95676B2C-601F-490E-BF06-C8B6DDFA2D6F

P356

AJPH.2004.056150

P1433

American Journal of Public Health

P1476

Feasibility and Outcome of HCV Treatment in a Canadian Federal Prison Population

@en

P2093

Benedikt Fischer

http://www.w3.org/2001/XMLSchema#string

Emma Haydon

http://www.w3.org/2001/XMLSchema#string

John Farley

http://www.w3.org/2001/XMLSchema#string

Shawn Vasdev

http://www.w3.org/2001/XMLSchema#string

Theresa A Farley

http://www.w3.org/2001/XMLSchema#string

P2860

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Two-sided confidence intervals for the single proportion: comparison of seven methods

Impact of adherence on the outcome of antiviral therapy for chronic hepatitis C.

Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?

HIV and hepatitis C virus testing and seropositivity rates in Canadian federal penitentiaries: A critical opportunity for care and prevention.

Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.

Management of viral hepatitis: clinical and public health perspectives--a consensus statement. CASL Hepatitis Consensus Group. Canadian Association for Study of the Liver.

Prior opiate injection and incarceration history predict injection drug use among inmates.

Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?

Treatment of chronic hepatitis C in a state correctional facility.

P304

1737-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2105/AJPH.2004.056150

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7628613

http://www.w3.org/2001/XMLSchema#string

P698

16131642

http://www.w3.org/2001/XMLSchema#string

P932

1449428

http://www.w3.org/2001/XMLSchema#string